Taguchi Takura, Yoshioka Daisuke, Toda Koichi, Miyagawa Shigeru
Department of Cardiovascular Surgery, Osaka University Graduate School of Medicine, 2-2-E1, Yamadaoka, Suita, Osaka 565-0871, Japan.
Eur Heart J Case Rep. 2023 Nov 15;8(1):ytad557. doi: 10.1093/ehjcr/ytad557. eCollection 2024 Jan.
Heart transplantation is the gold standard therapy for end-stage heart failure; however, it is limited by a shortage of available donors. In recent years, heart transplantations have been performed using marginal donor hearts with valvular and/or congenital cardiac abnormalities.
A 60-year-old woman with acromegalic cardiomyopathy underwent left ventricular assist device implantation and aortic valve (AV) closure 4 years prior. After 2 months, repeat AV closure and omental flap transposition were performed. During the outpatient follow-up, the patient developed recurrent severe AV regurgitation and bacteraemia-induced subarachnoid haemorrhage. She underwent urgent heart transplantation using a marginal donor heart with preserved cardiac function, mild pulmonary valve stenosis, and regurgitation after pulmonary valve-sparing tetralogy of Fallot (TOF) repair. An anatomical anastomosis was possible. She had no signs of infection, heart failure, arrhythmia, or immune rejection 15 months after the heart transplantation.
In this case, the donor heart with repaired TOF did not require pulmonary valve replacement and was anatomically intact. Donor hearts with repaired TOF that are expected to have long-term durability in terms of cardiac function may be used for successful heart transplantations. The repair of marginal donor hearts creates an opportunity to increase the number of viable donors.
心脏移植是终末期心力衰竭的金标准治疗方法;然而,它受到可用供体短缺的限制。近年来,已使用存在瓣膜和/或先天性心脏异常的边缘供体心脏进行心脏移植。
一名患有肢端肥大症性心肌病的60岁女性在4年前接受了左心室辅助装置植入和主动脉瓣关闭术。2个月后,进行了重复主动脉瓣关闭术和网膜瓣移位术。在门诊随访期间,患者出现复发性严重主动脉瓣反流和菌血症引起的蛛网膜下腔出血。她使用了一颗边缘供体心脏进行紧急心脏移植,该供体心脏保留了心脏功能,有轻度肺动脉瓣狭窄,并且在法洛四联症(TOF)修复术后存在肺动脉瓣反流。可以进行解剖吻合。心脏移植15个月后,她没有感染、心力衰竭、心律失常或免疫排斥的迹象。
在本病例中,经修复的TOF供体心脏不需要更换肺动脉瓣,并且解剖结构完整。预期在心脏功能方面具有长期耐久性的经修复的TOF供体心脏可用于成功的心脏移植。对边缘供体心脏进行修复为增加可用供体数量创造了机会。